Overall, there was a statistically significant increase in the use of calcium supplementation (92 [42.1%] before screening vs 156 [71.3%] after screening; P<.001). The use of HRT decreased significantly (P<.001) after screening, with just 25 (11.7%) women using HRT compared with 52 (23.9%) before screening. In addition, women with normal BMD were significantly more likely to report HRT use than those with low BMD (17 [22.7%] vs 9 [6.3%]; P<.001). There was no significant difference in the use of alendronate, calcitonin, and selective estrogen receptor modulators before and after screening. Although we did not have a baseline for comparison, 75 (34.4%) women reported an increase in exercise, and 46 (21.1%) reported an increase in dairy intake since the screening. There was no significant difference in the reported increase in exercise or dietary intake between the group with normal BMD and the group with low BMD.